Life Briefing: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says Strategic angle: Families report financial and treatment struggles after GSK's price increases on asthma inhalers. Editorial Staff Mar 16
Life Briefing: CMS’ New Approach to Federal Medicaid Spending in Cases of Potential Fraud Strategic angle: CMS has announced a new strategy focusing on pausing or withholding federal funding in potential fraud cases, impacting states and enrollees. Editorial Staff Mar 16
Life Briefing: A brain-computer interface allowed people with paralysis to type with their mind Strategic angle: Two people with paralysis were able to type using a brain-computer interface that decodes attempted finger movement, a new study showed. Editorial Staff Mar 16
Life Briefing: STAT+: Two more drugmakers join TrumpRx Strategic angle: Medicare delays stall breakthrough device access, ALS carriers fear research setbacks under Trump, and more biotech news Editorial Staff Mar 16
Life Structure Therapeutics Reports Significant Weight Loss from Mid-Stage GLP-1 Pill An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works. Editorial Staff Mar 16
Life Briefing: Disabled CDC staff still missing accommodations Strategic angle: The transformation of organ transplantation, an age to start considering statins, and other health news Editorial Staff Mar 16
Life Briefing: New technologies promise to transform organ transplantation. But when? Strategic angle: Perfusion technology vastly improves organ quality in transplants, but high costs and coverage questions pose barriers in becoming the standard of care. Editorial Staff Mar 16
Life Briefing: Opinion: Congress must pass legislation to ensure Medicare covers breakthrough medical technologies Strategic angle: Congress must pass bipartisan legislation to ensure Medicare coverage of breakthrough medical technologies, writes a physician and inventor. Editorial Staff Mar 16
Life Briefing: Opinion: I have a genetic mutation linked to ALS. The Trump administration terrifies me Strategic angle: "Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that." Editorial Staff Mar 16
Life Briefing: How STAT would cover ‘The Fugitive’ if its pharma scandal were real Strategic angle: It's Oscar season, so we're bringing you a special STATus report on how we'd cover the drug scandal in 'The Fugitive' if it were real. Editorial Staff Mar 13
Life Briefing: Major changes to cardiovascular guidelines suggest taking statins as young as 30 Strategic angle: Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks and strokes. Editorial Staff Mar 13
Life Briefing: STAT+: Up and down the ladder: The latest comings and goings Strategic angle: From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. Editorial Staff Mar 13
Life Briefing: Most Medicare Beneficiaries Affected by Plan Terminations in 2025 Have Robust Medicare Advantage Options in 2026 Strategic angle: Virtually all (98.9%) of the 2.6 million Medicare beneficiaries enrolled in a Medicare Advantage plan that terminated coverage at the end of 2025 have at least one MA-PD available in 2026. Editorial Staff Mar 13
Life Epstein’s pal attempts a biotech comeback, and Prasad exits the FDA On this week's The Readout LOUD podcast: A friend of Jeffrey Epstein attempts a biotech comeback, and (another) Prasad FDA exit. Editorial Staff Mar 13
Life Briefing: Trump's Influence on Drug Prices: A Closer Look Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden. Editorial Staff Mar 13
Life Recent Trends in Medicaid Outpatient Prescription Drugs and Spending This issue brief describes recent trends in the number of Medicaid outpatient prescriptions and the spending on those drugs and examines the implications of recent federal actions on future trends. Editorial Staff Mar 13
Life Briefing: Make next year’s flu shots, says FDA committee Strategic angle: Vaccine skepticism, FDA-authorized vape flavors, and more health news from Morning Rounds Editorial Staff Mar 13
Life Poll: Public Worries About Prescription Drug Costs Reach New High Most Across Political Parties Want Government to Do More to Regulate Prices Editorial Staff Mar 13
Life Briefing: Trump is getting more credit than Biden for efforts to lower drug prices Strategic angle: Trump is drawing more attention to his efforts to lower drug prices, like TrumpRx. Editorial Staff Mar 13
Life Briefing: FDA move on flavored vapes rattles public health experts Strategic angle: New FDA guidance suggests mint, coffee, and spice vape flavors could be authorized, raising debate over toxic additives and youth vaping risks. Editorial Staff Mar 13